Skip to main content


Associate Professor

Matthew Eisenberg, PhD, uses economics to analyze governmental, insurer, and employer healthcare policies with applications to mental health and substance use disorders.

Contact Info

624 N. Broadway, Hampton House 406

Research Interests

Health economics; health insurance; mental health; substance use disorder

Experiences & Accomplishments
Carnegie Mellon University
Cornell University

Matthew Eisenberg, PhD, is a health economist and Associate Professor of Health Policy and Management (primary), and, Mental Health (joint) at the Johns Hopkins Bloomberg School of Public Health, and at the Johns Hopkins Carey Business School (joint). At Johns Hopkins, he serves as Associate Chair for Faculty in the Department of Health Policy and Management, the Director of the PhD Program in Health Economics and Policy, the Director of the Center for Mental Health and Addiction Policy, and the Director of Research for the Hopkins Business of Health Initiative. He completed his BS, with honors, in Policy Analysis and Management at Cornell University and received his PhD in Public Policy and Management from Carnegie Mellon University with a specialization in Health Economics.

Much of his research has been focused on analyzing the impact of Federal, insurer, and employer level health care policies, specifically with applications to mental health and substance use disorder. In his work, he brings econometric research designs and economic theory to important policy questions with the goal of improving the functioning of health care markets and improving health. His work has won multiple best abstract awards at the Academy Health Annual Research Meeting (ARM), the top national conference for health services and health policy research. His teaching has won excellence in teaching awards for eight consecutive years.

He has published 60 peer-reviewed papers in top economics, medical, and policy journals including Journal of Health Economics, American Journal of Health Economics, JAMA, JAMA: Psychiatry, and Health Affairs. He is principal investigator of three R01s and received more than $10 million in funding in grants as principal investigator from the National Institutes for Health (NIH), Agency for Healthcare Research and Quality, and several prominent foundations. He believes strongly in translating research for impact and consults with numerous Federal and State policymakers to advise them on healthcare policy. He is currently the co-chair of an international, multi-disciplinary, Lancet Psychiatry commission aimed at bridging the research-implementation divide and scaling mental health treatment interventions. He was recently appointed by Governor Wes Moore to serve on a new statewide commission on Behavioral Health Treatment and Access.

Honors & Awards

Best of ARM Abstract. Selected as one of eight abstracts to be featured as the Best of the Academy Health Annual Research Meeting, 2020

Bloomberg School of Public Health Excellence in Teaching for Applied Microeconomics for Policymaking, 2019, 2021

Bloomberg School of Public Health Excellence in Teaching for Intermediate Health Economics, 2019, 2020, 2021, 2022, 2023

Bloomberg School of Public Health Excellence in Teaching for Health Economics II, 2016, 2017, 2018

Select Publications

Selected publications listed. A full CV can be found here:

  • Eisenberg MD, Eddelbuettel JC, McGinty EE. 2022. Employment in Office Based and Intensive Behavioral Health Settings in the U.S., 2016-2022. JAMA. 328(16): 1642-1643.

  • Eisenberg MD, Kennedy-Hendricks A, Schilling C, Busch A, Huskamp HA, Stuart L, Meiselbach M, Barry CL. 2022. The Impact of High-Deductible Health Plans on Substance Use Disorder Treatment Use and Spending. American Journal of Managed Care. 28(10): 500-506.

  • Eisenberg M, Du S, Kennedy-Hendricks A, Sen A, Barry CL. 2020. Health care spending by enrollees with substance use and mental health disorders in high-deductible health plans v traditional plans. JAMA Psychiatry. Published online April 15, 2020. doi:10.1001/jamapsychiatry.2020.0342

  • Eisenberg MD, Stone EM, Pittell H, McGinty EE. 2020. The impact of academic medical center policies restricting direct-to-physician marketing on opioid prescribing. Health Affairs. 39(6): 1002-1010.

  • Eisenberg M, Haviland A, Mehtora A, Huckfedlt P, Sood N. 2017. The Long-Term Effects of Consumer-Directed Health Plans on the Use of Preventive Care. Journal of Health Economics. 55:61-75